Navigation Links
Cell Biosciences Introduces First Protein Analysis Kits
Date:11/4/2008

PALO ALTO, Calif., Nov. 4 /PRNewswire/ -- Cell Biosciences, Inc., a provider of protein detection and characterization systems to life science researchers, today announced the launch of its first assay kits for the Firefly 3000(TM) Protein Analysis System. The Firefly 3000 is an ultrasensitive nano-immunoassay system that quantifies the phosphorylation of signaling proteins in samples as small as 25 cells.

The new Firefly 3000 Focusing Kits, Detection Kits, and Plate Kits were designed to provide highly reproducible analytical results in a convenient and flexible format. The kits are available with multiple separation ranges and multiple detection antibodies to address a wide range of assay requirements and workflows.

"I am pleased to announce the release of our first assay kits," said Wilhelm Lachnit, Ph.D., Vice President of Research and Development. "We are committed to providing innovative whole-product solutions to our customers, and these kits represent a significant step toward that goal."

About Cell Biosciences

Cell Biosciences is a private life sciences company focused on nano-proteomics. We develop instrumentation systems to enable the detection and characterization of specific proteins in extremely small biological samples. Our company's lead product, the Firefly 3000, is a capillary-based nanofluidic immunoassay platform that provides quantitative and reproducible data on key signaling pathways while conserving precious biological samples. Cell Biosciences is located in Palo Alto, CA. http://www.cellbiosciences.com

For additional information, please contact Walter Ausserer, Ph.D., Vice President of Marketing, Cell Biosciences, Inc. 650 859-1485


'/>"/>
SOURCE Cell Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Catalyst Biosciences Appoints Dr. Todd Lorenz Chief Medical Officer
2. Magellan Biosciences Companies to Feature Diagnostic Products Designed to Improve Health Outcomes at the Clinical Lab Expo
3. Monogram Biosciences Collaborates with Gilead Sciences for Elvitegravir Phase III Studies
4. Monogram Biosciences Announces Immediate Availability of Enhanced Sensitivity Trofile(TM) HIV Tropism Assay
5. Ardea Biosciences Announces Upcoming Corporate Meetings
6. Ardea Biosciences Reports Progress of Clinical Development Programs; Provides 2008 Outlook; Announces 2007 Financial Results and Provides 2008 Financial Guidance
7. Pressure BioSciences, Inc. Reports 2007 Financial Results and Provides Business Update
8. Pressure BioSciences, Inc. Announces Move to New Corporate Offices
9. Numira Biosciences Names New Board Member
10. DARA BioSciences, Inc. Announces Appointment of Dr. David J. Drutz to Board
11. DARA BioSciences, Inc. and Point Therapeutics, Inc. Announce Consummation of Merger
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... , ... December 07, 2016 , ... "Hacking into my ... had described him as 'a genius.'" Thus begins "Margaret in Berlin," Book Twelve in ... published by Wyston Books, Inc. These novels narrate the lives of a ...
(Date:12/6/2016)... ... December 06, 2016 , ... Men with gum ... risk of serious health problems, such as cardiovascular illness, according to research cited ... Beverly Hills Periodontics & Dental Implant Center notes that the correlation between periodontal ...
(Date:12/6/2016)... ... ... An inventor, from Talladega, Ala., thought there needed to be a more ... , The SLING-VEST provides an effective way to support and align the arm or ... result, it helps to reduce discomfort and shifting. The invention features an effective design ...
(Date:12/6/2016)... ... ... Mount Sinai Health System today announced the creation of the Medical Modeling ... order 3D models for their cases. Virtual reality, simulation, and 3D printing services ... resource will be the first of its kind catering to the unique patient-specific modeling ...
(Date:12/6/2016)... Scottsdale, Arizona (PRWEB) , ... December 06, 2016 , ... ... less than fIve days after launch. Almost 200 backers pledged more than $25,000 ... life-changing technology. , Dr. Amy Serin, an Arizona Neuropsychologist and inventor, ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)...  BTL Aesthetics today announced the release of ... ME device was effectively redesigned for more efficient, ... tissue. The result: Significantly better outcomes in abdominal ... ME versus BTL Vanquish. "We are ... patients with the most highly-advanced devices on the ...
(Date:12/6/2016)... 6, 2016  Arcturus Therapeutics, Inc. ("Arcturus" or ... today that it entered into collaboration with Takeda ... the treatment of NASH and other gastrointestinal (GI) ... LUNAR™ and UNA Oligomer chemistry. The financial terms ... commitment to and expertise in GI disorders, we ...
(Date:12/6/2016)... 6, 2016 A new study released today ... 340B) projects the 340B Drug Pricing Program will continue to ... it is expected to exceed $23 billion in total purchases ... purchases surpass current Medicare Part B drug reimbursement purchases over ... – based on analysis of data on total drug purchases ...
Breaking Medicine Technology: